LOS ANGELS: Police forcibly removed scores of defiant pro-Palestinian protesters at several colleges on Thursday, including taking
DRAP slashes price of COVID-19 drug
ISLAMABAD: In a major relief to coronavirus patients, the Drug Regulatory Authority of Pakistan (DRAP) on Monday reduced the price of remdesivir, the first and only approved treatment for COVID-19 in the United States, by Rs1,629 to Rs9,244.
In a notification, DRAP said that the price of remdesivir injection has been slashed by Rs1,629, adding that the antiviral drug will be sold at Rs9,244 across the country.
The regulatory authority warned that strict legal action will be taken against those who are selling the drug at higher prices.
It is pertaining to mention here that remdesivir has reportedly proved effective against the novel coronavirus and the federal cabinet had approved to reduce the price of the antiviral drug last month. In May, US pharmaceutical company Gilead had allowed Pakistan to produce the antiviral drug in the country.
You May Also Like
WASHINGTON: The US State Department said on Thursday that Washington supports Pakistan’s efforts to stabilise its economy,
KARAKORAM: At least 20 people died while 21 others were injured on Friday morning when a passenger bus overturned on the
